Showing results (1271-1280 of 1,299) with videos related to

Sort By:
Pageof 130
Journal of Virology|August 2, 2013
Later passages of neural progenitor cells from neonatal brain are more permissive for human cytomegalovirus infectionXing Pan, Xiao-Jun Li, Xi-Juan Liu, et al.
Bioorganic & Medicinal Chemistry Letters|January 6, 2012
AMG 837: a potent, orally bioavailable GPR40 agonistJonathan B Houze, Liusheng Zhu, Ying Sun, et al.
Acta Pharmacologica Sinica|March 17, 2022
Safety, tolerability, and pharmacokinetics of VV116, an oral nucleoside analog against SARS-CoV-2, in Chinese healthy subjectsHong-Jie Qian, Yu Wang, Meng-Qi Zhang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 DiabetesNarihiro Toda, Xiaolin Hao, Yasuyuki Ogawa, et al.
The Journal of Clinical Investigation|April 1, 2021
Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation testWenhua Liang, Zhiwei Chen, Caichen Li, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 28, 2026
Pathologic complete response after neoadjuvant immunochemotherapy: persistent recurrence risk highlights the need for stratified managementChang Yuan, Chunji Chen, Zhichao Liu, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 25, 2026
Association of immune-related adverse events with survival outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a national multicenter retrospective cohort study in ChinaChunji Chen, Chang Yuan, Zhichao Liu, et al.
Nature Communications|June 21, 2026
A structurally unique effector shared between vascular wilt fungi drives cotton and olive defoliationAndrea Doddi, Gabriel Lorencini Fiorin, Jinling Li, et al.
Cell Reports|June 1, 2022
Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapyYannan Xi, Benbo Song, Iris Ngan, et al.
Research Square|February 23, 2021
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationGalit Alter, Matthew Gorman, Nita Patel, et al.
Pageof 130